Antitubercular Drugs Development: Recent Advances in Selected Therapeutic Targets and Rational Drug Design
نویسندگان
چکیده
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), is a remarkably successful pathogen that has latently infected a third of the world population (Zhang et al., 2006). Infection occurs via aerosol, and inhalation of a few droplets containing M. tuberculosis bacilli is enough for lung infection (Hassan et al., 2006). After infection, M. tuberculosis pathogenesis occurs in two stages. The first is an asymptomatic state that can persist for many years in the host, called latent TB. The second stage requires only a weakened immune response to become activated (Zhang, 2004), then the bacteria begins replicating and causing characteristic symptoms such as cough, chest pain, fatigue and unexplained weight loss. If left untreated, the disease eventually culminates in death. The emergence of Human Immunodeficiency Virus (HIV) and the resultant Acquired Immune Deficiency Syndrome (AIDS) pandemic underlined the importance of reactivation of the disease and its potentially catastrophic outcome since over 50% of deaths among HIVinfected patients results from co-infection with M. tuberculosis with the two pathogens inducing each other’s replication, thus accelerating the collapse of the immune system (Cole & Alzari, 2007). While it is impossible to determine the exact number of cases, the latest World Health Organization (WHO) survey estimates that close to 2 million deaths occur every year, that there are approximately 8 million new cases annually, and that every third individual on the planet has been exposed to or infected by M. tuberculosis (Dye, 2006; Cole & Alzari, 2007). Although TB can be treated and even cured with chemotherapy, treatment is exceedingly lengthy and takes 6-9 months (Blumberg, et al., 2003). In addition to significant toxicity, lengthy therapy also causes poor patient compliance, which is a frequent cause for selection of drug resistant and often deadly multidrug resistant TB (MDR-TB) bacteria (Zang et al., 2006). Currently, TB chemotherapy is made up of a cocktail of first-line drugs, isoniazid (INH), Rifampicin (RIF), pyrazinamide (PZA) and ethambutol (EMB), which are given for six
منابع مشابه
Mycobacterium tuberculosis Molecular Determinants of Infection, Survival Strategies, and Vulnerable Targets
Mycobacterium tuberculosis is the causative agent of tuberculosis, an ancient disease which, still today, represents a major threat for the world population. Despite the advances in medicine and the development of effective antitubercular drugs, the cure of tuberculosis involves prolonged therapies which complicate the compliance and monitoring of drug administration and treatment. Moreover, th...
متن کاملProfessional rational drug and biological product design methods based on chemoinformatics as a novel science
Background: The use of new technologies in the field of drug discovery and development plays an important role in introducing new and effective drugs, optimizing the properties of existing drugs and, in general the development of various drug-dependent industries, as well as the general health of human, animal and plant communities. These methods provide new drugs at...
متن کاملRecent advances in nanoformulations for co-delivery of curcumin and chemotherapeutic drugs
The application of chemotherapy in cancer treatment has been limited due to cause side effects such as toxicity against normal cells and drug resistance. In recent years, numerous studies have been focused on using natural products with chemotherapeutic drugs to enhance therapeutic efficiency and reduce cytotoxicity. On the other hand, encapsulation of drugs into nanoparticles (NPs) can improve...
متن کاملAntitubercular inhaled therapy: opportunities, progress and challenges.
Pulmonary tuberculosis remains the commonest form of this disease and the development of methods for delivering antitubercular drugs directly to the lungs via the respiratory route is a rational therapeutic goal. The obvious advantages of inhaled therapy include direct drug delivery to the diseased organ, targeting to alveolar macrophages harbouring the mycobacteria, reduced risk of systemic to...
متن کاملIn-silico Metabolome Target Analysis Towards PanC-based Antimycobacterial Agent Discovery
Mycobacterium tuberculosis, the main cause of tuberculosis (TB), has still remained a global health crisis especially in developing countries. Tuberculosis treatment is a laborious and lengthy process with high risk of non compliance, cytotoxicity adverse events and drug resistance in patient. Recently, there has been an alarming rise of drug resistant in TB. In this regard, it is an unmet need...
متن کاملDesign, Synthesis and Antitubercular Evaluation of Novel Series of Pyrazinecarboxamide Metal Complexes
The interest in the synthesis of metallic complexes of different drugs to make them moreefficient in biological environment of the human body is seen for the last few decades. Widerange of metal complexes are already used in clinical practice which encourages additionalresearch for innovating new metal based drugs, such as metal-mediated antibiotics, antiparasitic,antiviral, antibacterial, and ...
متن کامل